In a patient with lobar pneumonia (productive cough, fever, chest pain, oxygen saturation 88%) receiving intravenous ceftriaxone, paracetamol, and tramadol, who becomes stable after one day, which medication should be discontinued?

Tramadol should be discontinued (Answer: B)

In a patient with lobar pneumonia who has become stable and improved after one day of treatment, tramadol is the medication that should be stopped. The patient's pain has likely resolved with clinical improvement, making continued opioid analgesia unnecessary and potentially harmful.

Rationale for Each Medication

Why Stop Tramadol (B):

• Pleuritic chest pain resolves rapidly with clinical improvement in pneumonia patients, typically within 24-48 hours of effective antibiotic therapy
• Guidelines recommend simple analgesia (paracetamol) for pleuritic pain, not opioids 1
• Tramadol carries risks of respiratory depression, constipation, and dependency - particularly concerning in a patient who recently had hypoxemia (SpO2 88%)
• Once the patient is stable and pain-free, continuing opioid therapy provides no benefit and only adds risk
• The normal platelet count confirms no bleeding complications requiring pain management

Why Continue Paracetamol (A):

• Paracetamol should be continued for fever management and residual discomfort
• BTS guidelines specifically recommend paracetamol for pleuritic pain relief in pneumonia 1
• It is safe, well-tolerated, and appropriate for symptomatic management during recovery
• Fever may persist for 48-72 hours even with clinical improvement

Why Continue Ceftriaxone (C):

• Ceftriaxone must absolutely be continued - stopping after only one day would be dangerous and inappropriate
• IDSA/ATS guidelines recommend minimum 5 days of antibiotic therapy, with patients needing to be afebrile for 48-72 hours before discontinuation 2
• The patient presented with severe pneumonia (lobar pneumonia with SpO2 88%), requiring full treatment course
• Early clinical improvement (within 24 hours) does not indicate infection eradication - this is merely initial response
• Premature antibiotic discontinuation leads to treatment failure, relapse, and increased mortality 2

Azithromycin (D):

• This medication was not part of the initial treatment regimen, making this option irrelevant to the question

Clinical Stability vs. Treatment Completion

Critical distinction: Clinical stability after one day means the patient is responding appropriately to therapy - it does NOT mean treatment is complete. The IDSA/ATS criteria for antibiotic discontinuation require 2:

• Minimum 5 days of therapy
• Afebrile for 48-72 hours
• No more than 1 sign of clinical instability
• Ability to take oral medications

This patient has met none of these criteria after just one day.

Common Pitfall

The most dangerous error would be stopping ceftriaxone prematurely. Early clinical improvement is expected and desirable, but the infection requires adequate duration of therapy to prevent relapse and complications. Studies show that patients with severe pneumonia who receive inadequate antibiotic duration have significantly higher mortality rates 2.